Congress has created a formal process to ensure that scientific judgment will guide them in future Alzheimer’s research funding. The Alzheimer’s Accountability Act, which was fully incorporated within the fiscal year 2015 funding bill signed into law by the President on December 17, 2014, ensures that funding levels determined by Congress are based on scientific recommendations of the National Institutes of Health. Funding for Alzheimer’s research was also increased by $25 million through this bill.
“In setting funding levels, Congress has told us that they want to hear directly from the nation’s top scientists. That’s exactly what the Alzheimer’s Accountability Act does by connecting scientists with appropriators,” said Harry Johns, president and CEO of the Alzheimer’s Association. “The Alzheimer’s Association urged the introduction and passage of this Act so that Congress understands what science will bring us to the day when there will be survivors of Alzheimer’s, just as there now are for the other major diseases in our country.”
For more information, click here.